DAUNOXOME Side Effects

6479865-8 | Hypertension, Pneumonia Adenoviral, Renal Impairment
on Nov 23, 2009 Female patient from UNITED KINGDOM , child 1 years of age, was diagnosed with acute myeloid leukaemia and was treated with Daunoxome (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, pneumonia adenoviral, renal impairment. Daunoxome dosage: . During the same period patient was treated with ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), BUSULFAN (4 Mg/kg Daily Po) (View Busulfan Review and Busulfan Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CLOFARABINE (View Clofarabine Review and Clofarabine Label ), CYCLOPHOSPHAMIDE (60 Mg/kg Daily) (View Cyclophosphamide Review and Cyclophosphamide Label ), MELPHALAN (140 Mg/sqm Daily) (View Melphalan Review and Melphalan Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6358989-X | Acute Myeloid Leukaemia Recurrent, Adenovirus Infection, Pulmonary Hypertension, Renal Impairment, Stem Cell Transplant
Patient was taking Daunoxome (View Usage). Patient had the following side effects: acute myeloid leukaemia recurrent, adenovirus infection, pulmonary hypertension (What is pulmonary hypertension?), renal impairment, stem cell transplant on Aug 26, 2009 from UNITED KINGDOM Additional patient health information: Female patient , child 1 years of age, was diagnosed with prophylaxis against graft versus host disease, bone marrow conditioning regimen and. Daunoxome dosage: . During the same period patient was treated with ALEMTUZUMAB (View Alemtuzumab Review and Alemtuzumab Label ), BUSULFAN (View Busulfan Review and Busulfan Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CLOFARABINE (View Clofarabine Review and Clofarabine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MELPHALAN (140 Mg/sqm Daily) (View Melphalan Review and Melphalan Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

5727312-3 | Prurigo, Rash Vesicular, Thrombocytopenic Purpura
Adverse event was reported on Apr 15, 2008 by a Female patient taking Daunoxome (View Usage) (Dosage: 60 Mg/m2 Iv) . Location: FRANCE , 43 years of age, After Daunoxome was administered, patient had the following side effects: prurigo, rash vesicular, thrombocytopenic purpura. During the same period patient was treated with ARACYTINE (200 Mg/m2 Iv) (View Aracytine Review and Aracytine Label ), HEXTRIL (View Hextril Review and Hextril Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), AMIKLIN. MFR: NOT SPECIFIED (View Amiklin. Mfr: Not Specified Review and Amiklin. Mfr: Not Specified Label ), PRIMPERAN. MFR: NOT SPECIFIED (View Primperan. Mfr: Not Specified Review and Primperan. Mfr: Not Specified Label ), FORLAX (View Forlax Review and Forlax Label ), LUTENYL (View Lutenyl Review and Lutenyl Label ). Patient was hospitalized.

5285066-1 | Pneumonia
on Mar 23, 2007 Female patient from UNITED STATES , weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunoxome (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Daunoxome dosage: . During the same period patient was treated with ELSPAR (View Elspar Review and Elspar Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.


5263894-6 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Herpes Simplex, Pyrexia
on Mar 01, 2007 Male patient from FRANCE , 43 years of age, weighting 143.3 lb, was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?), hiv infection (What is hiv infection?) and was treated with Daunoxome (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, herpes simplex (What is herpes simplex?), pyrexia. Daunoxome dosage: . During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), TMC114 (View Tmc114 Review and Tmc114 Label ). Patient was hospitalized.

5215922-1 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased
Patient was taking Daunoxome (View Usage). After Daunoxome was administered, patient had the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased on Jan 11, 2007 from FRANCE Additional patient health information: Male patient , 43 years of age, weighting 143.3 lb, was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?), herpes virus infection, pyrexia, hiv infection (What is hiv infection?) and. Daunoxome dosage: . During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), EPIVIR (View Epivir Review and Epivir Label ), NORVIR (View Norvir Review and Norvir Label ), TMC114 (View Tmc114 Review and Tmc114 Label ). Patient was hospitalized.

5196176-1 | Cardiac Failure, Hepatitis, Renal Failure Acute, Respiratory Distress, Shock
Adverse event was reported on Dec 20, 2006 by a Female patient taking Daunoxome (View Usage) (Dosage: ) . Location: FRANCE , 26 years of age, weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure, hepatitis (What is hepatitis?), renal failure acute, respiratory distress, shock. During the same period patient was treated with ARACYTINE (View Aracytine Review and Aracytine Label ).

5102082-0 | Accidental Overdose, Aplasia, Cardiac Arrest, Chills, Pain, Prostration, Respiratory Distress, Vomiting
on Aug 23, 2006 Female patient from FRANCE , weighting 22.05 lb, was diagnosed with acute leukaemia, acute myeloid leukaemia, nausea (What is nausea?), tumour lysis syndrome, agranulocytosis, antibiotic prophylaxis and was treated with Daunoxome (View Usage). Patient had the following side effects: accidental overdose, aplasia, cardiac arrest (What is cardiac arrest?), chills, pain (What is pain?), prostration, respiratory distress, vomiting. Daunoxome dosage: . During the same period patient was treated with ARACYTINE (View Aracytine Review and Aracytine Label ), ZOPHREN (View Zophren Review and Zophren Label ), FASTURTEC (View Fasturtec Review and Fasturtec Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ), GRANOCYTE (View Granocyte Review and Granocyte Label ), PLITICAN (View Plitican Review and Plitican Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

5035738-9 | Bone Marrow Disorder, Cardiac Failure
on Jun 16, 2006 Female patient from FRANCE , child 8 years of age, was treated with Daunoxome (View Usage). After Daunoxome was administered, patient had the following side effects: bone marrow disorder, cardiac failure. Daunoxome dosage: . During the same period patient was treated with VINDESINE (View Vindesine Review and Vindesine Label ). Patient was hospitalized.

5033888-4 | Cardiac Failure, Ejection Fraction Decreased
Patient was taking Daunoxome (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, ejection fraction decreased on Jun 16, 2006 from FRANCE Additional patient health information: Female patient , child 8 years of age, . Daunoxome dosage: . During the same period patient was treated with VINDESINE (View Vindesine Review and Vindesine Label ). Patient was hospitalized.

4673057-0 | Cyanosis, Dyspnoea
Adverse event was reported on Nov 09, 2000 by a Male patient taking Daunoxome (View Usage) (Dosage: Intravenous) was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?) and. Location: , 50 years of age, weighting 157.6 lb, Patient had the following side effects: cyanosis, dyspnoea. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), SOLU DECORTIN (PREDNISONE) (View Solu Decortin (prednisone) Review and Solu Decortin (prednisone) Label ), ISOZID (ISONIAZID) (View Isozid (isoniazid) Review and Isozid (isoniazid) Label ). Patient was hospitalized.

4673056-9 | Condition Aggravated, Depression, Diarrhoea, Prostatic Disorder
on Nov 06, 2000 Male patient from , 29 years of age, weighting 136.7 lb, was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?) and was treated with Daunoxome (View Usage). After Daunoxome was administered, patient had the following side effects: condition aggravated, depression (What is depression?), diarrhoea, prostatic disorder. Daunoxome dosage: Intravenous. During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), ALUMINUM AND MAGNES (ALUMINUM MAGNESIUM SILICATE) (View Aluminum And Magnes (aluminum Magnesium Silicate) Review and Aluminum And Magnes (aluminum Magnesium Silicate) Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ). Patient was hospitalized.

4673055-7 | Non-hodgkin's Lymphoma
on Nov 09, 2000 Male patient from , 46 years of age, weighting 154.3 lb, was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?) and was treated with Daunoxome (View Usage). Patient experienced the following unwanted or unexpected effects: non-hodgkin's lymphoma. Daunoxome dosage: Intravenous. During the same period patient was treated with SELEN (SELEN MED NATURLIGT E VITAMIN) (View Selen (selen Med Naturligt E-vitamin) Review and Selen (selen Med Naturligt E-vitamin) Label ), WOBENZYME (WOBENZYME) (View Wobenzyme (wobenzyme) Review and Wobenzyme (wobenzyme) Label ), ZINK (ZINC) (View Zink (zinc) Review and Zink (zinc) Label ), COTRIMOXAZOL (BACTRIM) (View Cotrimoxazol (bactrim) Review and Cotrimoxazol (bactrim) Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), HYDROXYZIN (HYDROXYZINE) (View Hydroxyzin (hydroxyzine) Review and Hydroxyzin (hydroxyzine) Label ). Patient was hospitalized.

4673054-5 | Pleural Effusion
Patient was taking Daunoxome (View Usage). Patient had the following side effects: pleural effusion on Nov 17, 2000 from Additional patient health information: Male patient , 46 years of age, weighting 126.8 lb, was diagnosed with kaposi's sarcoma (What is kaposi's sarcoma?) and. Daunoxome dosage: Intravenous. Patient was hospitalized.